CompletedPHASE1, PHASE2NCT02743377

PET Imaging of Phosphodiesterase-4 (PDE4) in Brain and Peripheral Organs of McCune-Albright Syndrome

Studying McCune-Albright syndrome

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: National Institute of Mental Health (NIMH)
Principal Investigator: Robert B Innis, M.D.
National Institute of Mental Health (NIMH)
Intervention: Brain PET Imaging with 11C Rolipram(other)
Enrollment: 16 enrolled
Eligibility: 18 years · All sexes
Timeline: 2018 – 2020

Study locations (1)

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02743377 on ClinicalTrials.gov

Other trials for McCune-Albright syndrome

Additional recruiting or active studies for the same condition.

RECRUITINGNCT00001727
Screening and Natural History of Patients With Polyostotic Fibrous Dysplasia and the McCune-Albright Syndrome
National Institute of Dental and Craniofacial Research (NIDCR)

See all trials for McCune-Albright syndrome →

← Back to all trials